Innovative non-invasive technology to treat prostate hyperplasia

The «REZUM» system: the new trend for the treatment of benign prostate hyperplasia (BPH) (prostate adenoma).

After being approved by the FDA in 2015, REZUM is introduced to Hôtel-Dieu de France for the first case in the Middle East.

This procedure was carried out by the team of the Urology Service thanks to an innovative non-invasive technology that uses water vapor to treat prostate hyperplasia with little or no side effects including sexual effect.